Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Breast Neoplasms 17Lung Neoplasms 15Colonic Neoplasms 11Head and Neck Neoplasms 9Rectal Neoplasms 7Glioblastoma 5Prostatic Neoplasms 4Precancerous Conditions 4Mouth Neoplasms 4Esophageal Neoplasms 4Central Nervous System Neoplasms 4Adenomatous Polyposis Coli 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Neuroblastoma 3Neoplasms 3Liver Neoplasms 3Gliosarcoma 3Glioma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Smoking 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2

Interventions

Tobacco Use Cessation Devices 5Counseling 5Early Intervention, Educational 3Bupropion 3Varenicline 2Nicotine Replacement Therapy 2Nicotine 2Community Health Workers 2Aspirin 2zileuton 1phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1Sulindac 1Risk Factors 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Methods 1Memantine 1Gene Expression Profiling 1Fertility 1Ethanol 1Drug Therapy 1Celecoxib 1Calcitriol 14-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tobacco Use Disorder × Celecoxib × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡